Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06047496 · ClinicalTrials.gov registry record · Early Phase 1

Time Restricted Eating in Sleep Apnea

A Early Phase 1 study of Obstructive Sleep Apnea and Time-restricted Eating, sponsored by University of California, San Diego.

Recruiting
Registry status
Early Phase 1
Development phase
80
Enrollment target
1
Study location

NCT06047496: Recruiting Early Phase 1 study of Obstructive Sleep Apnea and Time-restricted Eating, sponsored by University of California, San Diego.

NCT06047496 is a Early Phase 1 study of Obstructive Sleep Apnea and Time-restricted Eating that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 80 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06047496, a Early Phase 1 study of Obstructive Sleep Apnea and Time-restricted Eating, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
Early Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose levels and diabetes, obesity, and nonalcoholic fatty liver. While continuous positive airway pressure (CPAP), the best available OSA treatment, has been shown to improve blood pressure in OSA, it does not appear to improve metabolic consequences of OSA, and other therapies for OSA-induced dysmetabolism are needed. Animal models of time restricted eating (TRE) demonstrate an improvement in glucose and lipid metabolism, even in the absence of a reduction of caloric intake. Some human studies have shown an improvement in metabolic dysfunction with TRE, though further well-designed studies are needed. The effects of TRE on metabolic dysfunction in patients with OSA, a population with a high predisposition to metabolic disorder, has never been examined. In this study, we will conduct a randomized clinical trial to assess the feasibility and efficacy of 12 weeks of TRE, versus standard eating (SE), to improve glucose regulation and cardiovascular health of participants with OSA.

Primary Outcome

Change in mean daily glucose level over the study duration (measured in mg/dL), derived from continuous glucose monitoring (CGM), is the primary outcome.

Interventions

  • BEHAVIORAL Time restricted eating

Study Locations (1)

California

  • University of California San Diego (ACTRI) - La Jolla

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-01-05
Est. Completion 2028-12
Phase Early Phase 1
University of California, San Diego

775 total trials

What NCT06047496 shows while recruiting

NCT06047496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% lower).

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Time restricted eating is the first listed.

NCT06047496 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06047496 about?

NCT06047496 is a clinical study titled "Time Restricted Eating in Sleep Apnea". Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose levels and diabetes, obesity, and nonalcoholic fatty liver. While continuous positive airway pressure (CPAP), the best ava...

What is the current status of trial NCT06047496?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2024-01-05. Estimated completion is 2028-12.

What conditions does trial NCT06047496 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Time-restricted Eating.

What interventions are being tested in trial NCT06047496?

The interventions under investigation include: Time restricted eating (BEHAVIORAL).

Who is sponsoring clinical trial NCT06047496?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06047496 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06047496's enrollment target sits among peer trials

80 77th of 155 higher than 79 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06047496, the US trial registry maintained by the National Library of Medicine. NCT06047496 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.